Maurice R. Hilleman (NAS) is Director (formerly Senior Vice President) of the Merck Institute at Merck Research Laboratories in West Point, Pennsylvania. His career has been in basic and applied research on viruses, vaccines, immunology, and cancer. He is a long-time adviser to many health agencies including the Department of Health and Human Services, WHO, Overseas Medical Research Laboratory Committee of the Department of Defense (DOD), and special committees of the NAS and IOM.
Peter B. Jahrling is Scientific Adviser and Senior Research Scientist at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). He is head of the WHO collaborating center on arbovirus and hemorrhagic fever virus research at USAMRIID and a member of the Committee on Return of Biological Samples of the National Research Council's (NRC 's) Space Studies Board. He serves as a guest editor for a number of journals including the third and fourth editions of the Biosafety in Microbiological and Biomedical Laboratories. His research interests include development of vaccines, antiviral drugs, and effective treatment strategies for Ebola, Marburg, Lassa, and orthopox viruses.
James Leduc is Associate Director for Global Health in the National Center for Infectious Diseases at CDC. He is a fellow of the American College of Epidemiology and has received numerous awards for outstanding work in epidemiology. He has served as a Medical Officer of WHO and as an Officer at the United States Army Medical Research and Development Command. His research interests include epidemiology of virus diseases, especially viral hemorrhagic fevers and new, emerging and reemerging diseases.
Matthew Meselson (NAS, IOM) is Thomas Dudley Cabot Professor of Natural Sciences at Harvard University and codirector of the Harvard-Sussex program on chemical and biological warfare armament and arms limitation. He has conducted research mainly in the field of molecular genetics and is recipient of the NAS Award in Molecular Biology, the Eli Lilly Award in Microbiology, and the Thomas Hunt Morgan Medal of the Genetics Society of America. He is a member of the Royal Society and the Academie des Sciences and has served as a consultant on chemical and biological weapons matters to U.S. government agencies.
Thomas Monath is Vice President of Research and Development at OraVax and Adjunct Professor at the Harvard School of Public Health. He has been engaged in programs of WHO and the National Vaccines Advisory Committee. He was formerly director of the Division of Vector-Borne Infectious Diseases, CDC, and Chief of Virology, USAMRIID. His research has included work on arboviruses, viral hemorrhagic fevers, bubonic plague, and other zoonotic diseases. He has served on various committees dealing with biological weapons (BW) issues.
Frederick A. Murphy is Professor at the School of Veterinary Medicine at the University of California-Davis. Formerly, he was dean of the school and earlier he was the director of the National Center for Infectious Diseases at CDC. He is recipient of the Presidential Rank Award and is a member of the German Academy of Natural Sciences. He has been a leader in viral pathogenesis, viral characterization, and taxonomy; his interests include public health policy, vaccine development, and new, emerging and reemerging diseases.
Major General Philip K. Russell (retired U.S. Army) is Professor of International Health at the School of Hygiene and Public Health, Johns Hopkins University. He received the Distinguished Service Medal before retiring from military service. He has served on numerous scientific committees including advisory committees to the CDC and WHO. He was also involved in the establishment of medical research facilities at military bases around the world.